EVGN
Evogene Ltd.
0.43
2 x 0.29
2 x 0.55
bid
ask
-
0.01
2.47%
09:34 AM
timesize
Ytd-60.90%
1y-67.90%
0.42
day range
0.45
0.37
52 week range
1.50
Open0.42Prev Close0.44Low0.42High0.45Mkt Cap5.21M
Vol32.37KAvg Vol1.11MEPS-1.70P/EN/AForward P/E-0.39
Beta1.08Short Ratio0.04Inst. Own11.12%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-2050-d Avg0.66200-d Avg0.951yr Est8.13

EVGN News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark

Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization
prnewswire.com
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Tow

Integration of agentic computational systems enables the early-stage definition of key clinical and

Full Transcript: Evogene Q1 2026 Earnings Call
benzinga.com
Full Transcript: Evogene Q1 2026 Earnings Call

Evogene to Present Its Pharma Division Achievements at the BIO International Convention
prnewswire.com
Evogene to Present Its Pharma Division Achievements at the BIO International Convention

Conference to be held in San Diego, CA, USA – June 22-25, 2026 REHOVOT, Israel, June 9, 2026 /PRNews

benzinga.com
Evogene Completes First-In-Human Phase 1 Clinical Study Of BMC128, Rationally-Designed Live Bacteria

Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical ActivityREHO

benzinga.com
Evogene Reports Early Results for Cancer Therapy Study, Experimental Treatment Meets Safety Goal in

Evogene Ltd. ("Evogene") (NASDAQ:EVGN) (TASE: EVGN), a pioneering computational chemistry co

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
prnewswire.com
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed L

Study Results Demonstrated Favorable Safety Profile and Preliminary Signals of Clinical Activity REH

EverGen Infrastructure Corp. (EVGN:CA) Q1 2026 Earnings Call Transcript
seekingalpha.com
EverGen Infrastructure Corp. (EVGN:CA) Q1 2026 Earnings Call Transcript

EverGen Infrastructure Corp. (EVGN:CA) Q1 2026 Earnings Call Transcript

EverGen Infrastructure Reports Q1 2026 Results
businesswire.com
EverGen Infrastructure Reports Q1 2026 Results

VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Compan

Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript
seekingalpha.com
Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript

Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript

Earnings Scheduled For May 20, 2026
benzinga.com
Earnings Scheduled For May 20, 2026

benzinga.com
Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.60) per share which missed the analyst consen

Evogene Reports First Quarter 2026 Financial Results
prnewswire.com
Evogene Reports First Quarter 2026 Financial Results

Conference call and webcast: today, May 20, 2026, 9:00 AM ET REHOVOT, Israel, May 20, 2026 /PRNewswi

Evogene to Present at the 24th Schrödinger European User Group Meeting
prnewswire.com
Evogene to Present at the 24th Schrödinger European User Group Meeting

Conference will be held in Munich, Germany - May 19-21, 2026 REHOVOT, Israel, May 12, 2026 /PRNewswi

Evogene Schedules First Quarter 2026 Financial Results Release
prnewswire.com
Evogene Schedules First Quarter 2026 Financial Results Release

Zoom conference call scheduled for May 20, 2026, 9:00 AM ET REHOVOT, Israel, May 7, 2026 /PRNewswire

EverGen Infrastructure Corp. (EVGN:CA) Q4 2025 Earnings Call Transcript
seekingalpha.com
EverGen Infrastructure Corp. (EVGN:CA) Q4 2025 Earnings Call Transcript

EverGen Infrastructure Corp. (EVGN:CA) Q4 2025 Earnings Call Transcript

EverGen Infrastructure Reports Q4 & Year End 2025 Results
businesswire.com
EverGen Infrastructure Reports Q4 & Year End 2025 Results

VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Compan

Evogene (NASDAQ:EVGN) Stock Crosses Below 200 Day Moving Average   – Here’s Why
defenseworld.net
Evogene (NASDAQ:EVGN) Stock Crosses Below 200 Day Moving Average – Here’s Why

Evogene Ltd. (NASDAQ: EVGN - Get Free Report) shares crossed below its 200-day moving average during

benzinga.com
Evogene Receives Nasdaq Noncompliance Notification, Gets Time Through Sept. 28 To Regain Compliance

Evogene Ltd. (NASDAQ:EVGN)(TASE: EVGN) (the "Company", "Evogene"), a pioneering comp

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
prnewswire.com
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

REHOVOT, Israel, April 2, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN)(TASE: EVGN) (the "Company

Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
prnewswire.com
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promisi

Today, castor oil is a premium sustainable industrial feedstock for bio-based products REHOVOT, Isra

Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
prnewswire.com
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

Conference will be held at Lisbon, Portugal - March 23–25, 2026 REHOVOT, Israel, March 9, 2026 /PRNe

Evogene Q4 Earnings Call Highlights
defenseworld.net
Evogene Q4 Earnings Call Highlights

Evogene (NASDAQ: EVGN) executives used the company's fourth-quarter and full-year 2025 results call

Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
seekingalpha.com
Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript

Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript

Evogene Earnings Review: Q4 Summary
benzinga.com
Evogene Earnings Review: Q4 Summary

Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

Conference call and webcast: today, March 05, 2026, 9:00 AM ET REHOVOT, Israel, March 5, 2026 /PRNew

Earnings Scheduled For March 5, 2026
benzinga.com
Earnings Scheduled For March 5, 2026

An Overview of Evogene's Earnings
benzinga.com
An Overview of Evogene's Earnings

benzinga.com
Evogene Ltd. To Focus On ChemPass AI, Streamlines Operations To Drive Long-Term Value In Pharma And

Updating on Strategic Progress and OutlookREHOVOT, Israel, Feb. 25, 2026 /PRNewswire/ -- Evogene Ltd

Evogene Releases CEO Letter to Shareholders
prnewswire.com
Evogene Releases CEO Letter to Shareholders

Updating on Strategic Progress and Outlook REHOVOT, Israel, Feb. 25, 2026 /PRNewswire/ -- Evogene Lt

Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
prnewswire.com
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release

Zoom conference call scheduled for March 5, 2026, 9:00 AM ET REHOVOT, Israel, Feb. 19, 2026 /PRNewsw

benzinga.com
Evogene Partners With Research Group Of Dr. Mark Adams Over Discovery, Optimization Of Small Molecul

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry company specializing

benzinga.com
Evogene, Systasy And LMU University Hospital Collaborate To Accelerate Development Of Therapies For

The collaboration is supported by a pan-European EUREKA grant, with participation of the Weizmann In

benzinga.com
Evogene Announced An Expanded Phase Of Its Collaboration With Google Cloud That Would Focus On Devel

This announcement marks the second major milestone in the partnership between Evogene and Google Clo

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Evogene's Subsidiary Biomica Inks Exclusive Worldwide Licensing Agreement With Shanghai Lishan Bioph

BMC128 was developed by Biomica and is currently completing a Phase 1 clinical study, showing promis

benzinga.com
Evogene Collaborates With Unravel Biosciences To Accelerate Discovery, Optimization Of Small-Molecul

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other de

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

benzinga.com
Evogene Q3 EPS $(0.31) Beats $(0.41) Estimate, Sales $312.000K Miss $650.000K Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.31) per share which beat the analyst consensu

Earnings Scheduled For November 20, 2025
benzinga.com
Earnings Scheduled For November 20, 2025

What's Next: Evogene's Earnings Preview
benzinga.com
What's Next: Evogene's Earnings Preview

benzinga.com
Earnings Scheduled For August 19, 2025

benzinga.com
Preview: Evogene's Earnings

Dow Gains 50 Points; US Small Business Optimism Index Rises In May
benzinga.com
Dow Gains 50 Points; US Small Business Optimism Index Rises In May

US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results
benzinga.com
US Stocks Mixed; JM Smucker Shares Plunge After Q4 Results

benzinga.com
Lake Street Maintains Buy on Evogene, Lowers Price Target to $3.5

Lake Street analyst Ben Klieve maintains Evogene (NASDAQ:EVGN) with a Buy and lowers the price ta

benzinga.com
Evogene Q1 EPS $(0.38) Beats $(0.63) Estimate, Sales $2.44M Miss $4.42M Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.38) per share which beat the analyst consensu

benzinga.com
Earnings Scheduled For May 21, 2025

benzinga.com
Insights into Evogene's Upcoming Earnings

benzinga.com
ICL To Acquire Majority Activity Of Evogene's Subsidiary Lavie Bio; Term Not Disclosed

Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biologica